Axel Rufer

Luzern, LU, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.

Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.

Journal: Experimental hematology & oncology
Published: June 21, 2026

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

Journal: Journal of hematology & oncology
Published: March 15, 2026

Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis Network.

Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis Network.

Journal: Swiss medical weekly
Published: August 14, 2025

Hereditary alpha-tryptasemia - a potential cause of severe anaphylactic reactions and a modifier of mast cell diseases.

Hereditary alpha-tryptasemia - a potential cause of severe anaphylactic reactions and a modifier of mast cell diseases.

Journal: Swiss medical weekly
Published: June 01, 2025

Management of common autoimmune diseases in patients with myeloproliferative neoplasms treated with pegylated interferon alfa-case report, review of the literature and multidisciplinary clinical practice recommendations.

Management of common autoimmune diseases in patients with myeloproliferative neoplasms treated with pegylated interferon alfa-case report, review of the literature and multidisciplinary clinical practice recommendations.

Journal: Therapeutic advances in hematology
Published: November 17, 2024

Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.

Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.

Journal: Swiss medical weekly
Published: October 28, 2024

Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis.

Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis.

Journal: Leukemia
Published: July 20, 2024

Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery.

Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery.

Journal: Cancers
Published: April 27, 2024

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.

Journal: Leukemia
Published: April 12, 2024

Immunomodulation with romiplostim as a second-line strategy in primary immune thrombocytopenia: The iROM study.

Immunomodulation with romiplostim as a second-line strategy in primary immune thrombocytopenia: The iROM study.

Journal: British journal of haematology
Published: June 19, 2023

Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP.

Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP.

Journal: British journal of haematology
Published: June 16, 2023

Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET.

Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET.

Journal: HemaSphere
Published: December 28, 2022
Showing 1-12 of 32

Last Updated: 09/26/2026